Catalyst Biosciences (CBIO) Earnings Date, Estimates & Call Transcripts → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free CBIO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share EarningsStock AnalysisDividendEarningsOwnershipSocial MediaSustainabilityStock AnalysisDividendEarningsOwnershipSocial MediaSustainability Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCBIO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CBIO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 Catalyst Biosciences Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.16) EPSNext Year EPS Consensus Estimate: ($0.03) EPS Catalyst Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript8/17/2023Q2 2023($0.07)($0.07)-($0.07)--5/15/2023Q1 2023-($0.11)($0.11)($0.23)--3/30/2023Q4 2022-($1.28)($1.28)($1.28)--11/14/2022Q3 2022-($0.16)($0.16)($0.16)--8/15/2022Q2 2022($0.22)($0.18)+$0.04($2.00)--5/9/2022Q1 2022($0.56)($0.46)+$0.10($0.46)-$0.79 million Get the Latest News and Ratings for CBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Catalyst Biosciences and its competitors with MarketBeat's FREE daily newsletter. 3/31/2022Q4 2021($0.54)($0.64)($0.10)($0.64)$0.50 million$2.44 million11/12/2021Q3 2021($0.66)($0.80)($0.14)($0.80)$1.00 million$2.30 million8/5/2021Q2 2021($0.70)($0.64)+$0.06($0.64)$1.00 million$1.13 million5/6/2021Q1 2021($0.58)($0.79)($0.21)($0.79)$1.00 million$1.47 million Catalyst Biosciences Earnings - Frequently Asked Questions How much revenue does Catalyst Biosciences generate each year? Catalyst Biosciences (NASDAQ:CBIO) has a recorded annual revenue of $790,000.00. How much profit does Catalyst Biosciences generate each year? Catalyst Biosciences (NASDAQ:CBIO) has a recorded net income of -$8.24 million. CBIO has generated -$1.38 earnings per share over the last four quarters. What is Catalyst Biosciences's EPS forecast for next year? Catalyst Biosciences's earnings are expected to grow from ($0.16) per share to ($0.03) per share in the next year. More Earnings Resources from MarketBeat Related Companies: XOMA Earnings Verastem Earnings Vanda Pharmaceuticals Earnings Rigel Pharmaceuticals Earnings Regulus Therapeutics Earnings Lexicon Pharmaceuticals Earnings Emergent BioSolutions Earnings Aclaris Therapeutics Earnings Equillium Earnings AcelRx Pharmaceuticals Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:CBIO) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalyst Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
